TADAM 10 Israel - English - Ministry of Health

tadam 10

unipharm ltd, israel - tadalafil - film coated tablets - tadalafil 10 mg - tadalafil - for the treatment of erectile dysfunction in adult men.

TADAM 20 Israel - English - Ministry of Health

tadam 20

unipharm ltd, israel - tadalafil - film coated tablets - tadalafil 20 mg - tadalafil - for the treatment of erectile dysfunction in adult men.

TADAM 5 Israel - English - Ministry of Health

tadam 5

unipharm ltd, israel - tadalafil - film coated tablets - tadalafil 5 mg - tadalafil - for the treatment of erectile dysfunction in adult men.treatment of the signs and symptoms of benign prostatic hyperplasia (bph)treatment of ed and the signs and symptoms of bph (ed/bph)

CLOBETASOL PROPIONATE TRIMA SCALP SOLUTION Israel - English - Ministry of Health

clobetasol propionate trima scalp solution

trima israel pharmaceutical products maabarot ltd - clobetasol propionate - solution - external - clobetasol propionate 0.05 %w/w - clobetasol - for the topical treatment of inflammatory conditions of the scalp responsive only to corticosteroids.

AMLOW 5 Israel - English - Ministry of Health

amlow 5

unipharm ltd, israel - amlodipine as maleate - tablets - amlodipine as maleate 5 mg - amlodipine - amlodipine - mild to moderate hypertension. vasospastic angina (prinzmetal's or variant angina). chronic stable angina.

AMLOW 10 Israel - English - Ministry of Health

amlow 10

unipharm ltd, israel - amlodipine as maleate - tablets - amlodipine as maleate 10 mg - amlodipine - amlodipine - mild to moderate hypertension. vasospastic angina (prinzmetal's or variant angina). chronic stable angina.

TADALIS TEVA  10 MG Israel - English - Ministry of Health

tadalis teva 10 mg

teva pharmaceutical industries ltd, israel - tadalafil - tablets - tadalafil 10 mg - tadalafil - for the treatment of erectile dysfunction in adult men.

PROVIRON Israel - English - Ministry of Health

proviron

bayer israel ltd - mesterolone - tablets - mesterolone 25 mg - mesterolone - mesterolone - androgen therapy. androgen deficiency or male infertility when associated with primary or secondary male hypogonadism.

MIRCERA 360 MCG0.6 ML Israel - English - Ministry of Health

mircera 360 mcg0.6 ml

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta - solution for injection - methoxy polyethylene glycol-epoetin beta 360 mcg / 0.6 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic kidney disease (ckd).

BINOCRIT 1000 IU 0.5 ML Israel - English - Ministry of Health

binocrit 1000 iu 0.5 ml

novartis israel ltd - epoetin alfa - solution for injection - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.binocrit® is indicated in adults in a predonation programme to increase the yield of autologous blood.treatment should only be given to patients with moderate anaemia (haemoglobin (hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.use should be restricted to patients with moderate anaemia (e.g. hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).